The prophylactic use of granulocyte-colony stimulating factor during remission induction is associated with increased leukaemia-free survival of adults with acute lymphoblastic leukaemia: A joint analysis of five randomised trials on behalf of the EWALL

European Journal of Cancer

Volumn 48, Issue 3, 2012, Pages 360-367

  Giebel, Sebastian ^a   Thomas, Xavier ^b   Hallbook, Helene ^c   Geissler, Klaus ^d   Boiron, Jean Michel ^e   Huguet, Francoise ^f   Koller, Elisabeth ^g   Jaeger, Ulrich ^h   Smedmyr, Bengt ^c   Hellmann, Andrzej ⁱ   Holowiecki, Jerzy ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^e HAUT LÉVÊQUE HOSPITAL   (France)

^f CHU PURPAN   (France)

^g HANUSCH HOSPITAL   (Austria)

^h MEDICAL UNIVERSITY OF VIENNA   (Austria)

ⁱ MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Acute lymphoblastic leukaemia; G CSF; Induction; Leukaemia free survival; Remission duration; Survival

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GROUPS BY AGE; HAZARD RATIO; HUMAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPENIA; OVERALL SURVIVAL; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; RISK REDUCTION; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DISEASE-FREE SURVIVAL; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; MULTIVARIATE ANALYSIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; YOUNG ADULT;

EID: 84856210648     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.11.023     Document Type: Article

References (24)

1. M.S. Aapro, J. Bohlius, and D.A. Cameron 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours Eur J Cancer 47 2011 8 32
2. T.J. Smith, J. Khatcheressian, and G.H. Lyman 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline J Clin Oncol 24 2006 3187 3205 (Pubitemid 46638957)
3. G.H. Lyman, N.M. Kuderer, and B. Djulbegovic Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis Am J Med 112 2002 406 411 (Pubitemid 34246271)
4. Bohlius J, Herbst C, Reiser M, Schwarzer G, Engert A. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma (Review). Cochrane Database Syst Rev 2008;4:CD003189.
5. N.M. Kuderer, D.C. Dale, J. Crawford, and G.H. Lyman Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review J Clin Oncol 25 2007 3158 3167 (Pubitemid 47218066)
6. G. von Minckwitz, M. Schwenkglenks, and T. Skacel Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropenia management: results from an integrated analysis Eur J Cancer 45 2009 608 617
7. R.A. Larson, R.K. Dodge, and C.A. Linker A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111 Blood 92 1998 1556 1564 (Pubitemid 28406859)
8. O.G. Ottmann, D. Hoelzer, and E. Gracien Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial Blood 86 1995 444 450
9. K. Geissler, E. Koller, and E. Hubmann Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia - a randomized phase-III study Blood 90 1997 590 596 (Pubitemid 27299098)
10. J. Holowiecki, S. Giebel, and S. Krzemien G-CSF administered in time-sequenced setting during remission induction and consolidation therapy of adult acute lymphoblastic leukemia has beneficial influence on early recovery and possibly improves long-term outcome: a randomized multicenter study Leuk Lymphoma 43 2002 315 325 (Pubitemid 34202110)
11. X. Thomas, J.M. Boiron, and F. Huguet Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study Hematol J 5 2004 384 394 (Pubitemid 39359274)
12. H. Hallbook, M. Bjorkholm, H. Hagglund, and B. Smedmyr Swedish Adult ALL Group. Does granulocyte colony-stimulating factor improve long-term outcome in adult acute lymphoblastic leukemia? Leuk Lymphoma 50 2009 1872 1874
13. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
14. D.R. Cox Regression models and life tables J Royal Soc B 34 1972 187 220
15. R. Bassan, and D. Hoelzer Modern therapy of acute lymphoblastic leukemia J Clin Oncol 29 2011 532 543
16. N.M. Kuderer, D.C. Dale, J. Crawford, L.E. Cosler, and G.H. Lyman Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients Cancer 106 2006 2258 2266 (Pubitemid 43673249)
17. C. Gisselbrecht, C. Haioun, and E. Lepage Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte Leuk Lymphoma 18 1997 289 300 (Pubitemid 27248180)
18. R. Pettengell, M. Schwenkglenks, and R. Leonard Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia study Support Care Cancer 6 2008 1299 1309
19. A. Bosly, D. Bron, and A. Van Hoof Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP Ann Hematol 87 2008 277 283 (Pubitemid 351445288)
20. W. Stock, M. La, and B. Sanford Adolescents and young adults with acute lymphoblastic leukemia (ALL) have improved outcomes when treated on pediatric oncology cooperative group treatment regimens: a comparison of Children's Cancer Group (CCG) and Cancer and Leukemia Group B (CALGB) studies Blood 112 2008 1646 1654
21. N. Boissel, M.F. Auclerc, and V. Lhéritier Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials J Clin Oncol 21 2003 774 780 (Pubitemid 46606434)
22. J.M. de Bont, B. Holt, and A.W. Dekker Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands Leukemia 18 2004 2032 2035 (Pubitemid 40028431)
23. R. Ramanujachar, S. Richards, and I. Hann Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials Pediatr Blood Cancer 48 2007 254 261 (Pubitemid 46238513)
24. H. Hallböök, G. Gustafsson, B. Smedmyr, S. Söderhäll, and M. Heyman Swedish Adult Acute Lymphocytic Leukemia Group; Swedish Childhood Leukemia Group. Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol Cancer 107 2006 1551 1561 (Pubitemid 44546916)